DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» ARAF
ARAF
Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling
Product Data Sheet
(Continued) Linkage Mapping and Polymorphisms
Drosophila and Human Transcriptomic Data Mining Provides Evidence for Therapeutic
Inhibition of ERK 1/2 Kinases Prevents Tendon Matrix Breakdown Ulrich Blache1,2,3, Stefania L
ARAF Acts As a Scaffold to Stabilize BRAF:CRAF Heterodimers
WO 2017/083562 Al 18 May 20 17 (18.05.2017) W P O P C T
Dema and Faust Et Al., Suppl. Material 2020.02.03
Network Impact of the SERT Ala56 Coding Variant
Supporting Information
14-3-3 Proteins Associate with Cdc25 Phosphatases DOUGLAS S
Oncogenic and Sorafenib-Sensitive ARAF Mutations in Lung Adenocarcinoma
Kinase Brochure (PDF)
Cooperating Oncogenes Converge to Regulate Cychn/Cdk Complexes
ARAF Recurrent Mutation Causes Central Conducting Lymphatic Anomaly Treatable with a MEK Inhibitor
Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
Xt GENE PANEL, for Use with Xt | 648 GENE PANEL REPORTS
List of Actionable Genes and Potential Matched Therapy
Top View
Supporting Information for “A High-Throughput Targeted Proteomic Approach for Comprehensive
(12) Patent Application Publication (10) Pub. No.: US 2016/0053301 A1 RAYMOND Et Al
Supplemental Table-1
1 the Dimer-Dependent Catalytic Activity of RAF Family Kinases Is Revealed Through 2 Characterizing Their Oncogenic Mutants 3 4 5 Jimin Yuan1, Wan Hwa Ng1, Paula Y.P
The Serine-Threonine Kinase TAO3 Promotes Cancer Invasion and Tumor Growth
Kin-2787, Is Active in Class Ii and Class Iii Braf Mutant Models
Gene List HTG Edgeseq Oncology Biomarker Panel
Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF And
Genes Interrogated by Mayocomplete Solid Tumor Panel
Araf Kinase Antagonizes Nodal-Smad2 Activity in Mesendoderm Development by Directly Phosphorylating the Smad2 Linker Region
Targeting Alterations in the RAF–MEK Pathway
NCI Acting Director's Report
Synthetic Lethality-Based Identification of Targets for Anticancer Drugs In
LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF And
Classification of Signalchem Proteins Acetyl/Methyltransferase Proteins
Functional Screen Identifies Kinases Driving Prostate Cancer Visceral and Bone Metastasis
ABL,ARG Uniref100 P00519 Proto-Oncogene Tyrosine-P Lys1
R Graphics Output
Cancer Genetics of Sporadic Colorectal Cancer: BRAF and PI3KCA Mutations, Their Impact on Signaling and Novel Targeted Therapies
Table S1: Time-Dependent Cancer Cell Proliferation Inhibition Potency by LY3295668
Pluripotent Stem Cells As Research Models: the Examples of Trinucleotide Repeat Instability and X-Chromosome Inactivation
Cancer Signaling
Gene List HTG Edgeseq Oncology Biomarker Panel
Xt GENE PANEL, for Use with Xt | 648 Gene Panel Reports
Differential Information Flow Details
Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
Characterization and Clustering of Kinase Isoform Expression in Metastatic Melanoma
LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors
UC Riverside UC Riverside Electronic Theses and Dissertations
ARAF Protein ARAF Protein
Physical and Genetic Mapping in the Proximal Short Arm of the X Chromosome